Crossmark

Streptococcus mitis Expressing Pneumococcal Serotype 1 Capsule

Crossref DOI link: https://doi.org/10.1038/s41598-018-35921-3

Published Online: 2018-12-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lessa, Fernanda C.

Milucky, Jennifer

Rouphael, Nadine G.

Bennett, Nancy M.

Talbot, H. Keipp

Harrison, Lee H.

Farley, Monica M.

Walston, Jeremy

Pimenta, Fabiana

Gertz, Robert E.

Rajam, Gowrisankar

Carvalho, Maria da Gloria

Beall, Bernard

Whitney, Cynthia G.
Funding

Funding for this research was provided by:

U.S. Department of Health & Human Services | Centers for Disease Control and Prevention (CDC-RFA-CK17-1701)

U.S. Department of Health & Human Services | Centers for Disease Control and Prevention (CDC-RFA-CK17-1701)

U.S. Department of Health & Human Services | Centers for Disease Control and Prevention (CDC-RFA-CK17-1701)

U.S. Department of Health & Human Services | Centers for Disease Control and Prevention (CDC-RFA-CK17-1701)

U.S. Department of Health & Human Services | Centers for Disease Control and Prevention (CDC-RFA-CK17-1701)

U.S. Department of Health & Human Services | Centers for Disease Control and Prevention (CDC-RFA-CK17-1701)

U.S. Department of Health & Human Services | Centers for Disease Control and Prevention (CDC-RFA-CK17-1701)

U.S. Department of Health & Human Services | Centers for Disease Control and Prevention (CDC-RFA-CK17-1701)

U.S. Department of Health & Human Services | Centers for Disease Control and Prevention (CDC-RFA-CK17-1701)

U.S. Department of Health & Human Services | Centers for Disease Control and Prevention (CDC-RFA-CK17-1701)

U.S. Department of Health & Human Services | Centers for Disease Control and Prevention (CDC-RFA-CK17-1701)

U.S. Department of Health & Human Services | Centers for Disease Control and Prevention (CDC-RFA-CK17-1701)

U.S. Department of Health & Human Services | Centers for Disease Control and Prevention (CDC-RFA-CK17-1701)

U.S. Department of Health & Human Services | Centers for Disease Control and Prevention (CDC-RFA-CK17-1701)
License Information

Text and Data Mining valid from 2018-12-19

Version of Record valid from 2018-12-19
More Information

Article History

Received: 13 August 2018

Accepted: 8 November 2018

First Online: 19 December 2018

Competing Interests

: Dr. Lee Harrison has served on a scientific advisory board for GlaxoSmithKline, and has been a speaker at a Merck scientific symposium. However, none of these commitments had an influence on the design and interpretation of the data. All other authors report no competing financial or non-financial interests related to the work described.

Document is current

Any future updates will be listed below